PPH is defined as the excess amount of blood loss (more than 500 ml) after the delivery of child from vagina, uterus, cervix, and perineum. Increase in incidence of pregnancy-related complications, including multiple pregnancies, inverted uterus, large baby size, surge in risk factors, which causes PPH, including uterine atony, trauma, retained placenta, and bleeding disorders, and technological advancements in the recently approved devices drive the postpartum hemorrhage devices market growth. However, lack of trained professionals and healthcare services in developing countries hampers the market growth.
List of Key Players
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1676
Key Findings Of The Study
For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1676
Region-wise, North America dominated the postpartum hemorrhage devices market in 2020, and is expected to be dominant during the forecast period, owing to rise in the PPH cases and availability of advanced healthcare facilities. However, Asia-Pacific is expected to register highest CAGR of 6.4% from 2021 to 2030, owing to increase in rate of anemia among women in the region, which, in turn, increases the risk of postpartum hemorrhage. In addition, rise in awareness about PPH complications and increase in healthcare expenditure fuel the growth of global PPH device market.